The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...

As of 5 October 2024, a total of 17,579 pertussis cases had been reported in residents in the US (excluding territories).

NovoCure’s Optune Lua, a wearable indicated for patients with metastatic non-small cell lung cancer has received approval ...

The upcoming two-day event delves into the clinical trial landscape and the strategies employed to increase the region’s ...

Genprex received approval to proceed to the highest dose in the Phase I Acclaim-3 trial of Reqorsa for ES-small cell lung ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) expects the new UK clinical trial regulation to be ...

Airway Therapeutics is to launch a Phase III trial of zelpultide alfa, a drug to prevent bronchopulmonary dysplasia in ...